These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 34250945)

  • 21. Heterogeneity of cognitive impairments in myotonic dystrophy type 1 explained by three distinct cognitive profiles.
    Davion JB; Tard C; Fragoso L; Wilu-Wilu A; Skrobala E; Defebvre L; Delbeuck X
    J Neurol; 2024 Jul; 271(7):4529-4539. PubMed ID: 38709306
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Change over time in ability to perform activities of daily living in myotonic dystrophy type 1.
    Landfeldt E; Nikolenko N; Jimenez-Moreno C; Cumming S; Monckton DG; Faber CG; Merkies ISJ; Gorman G; Turner C; Lochmüller H
    J Neurol; 2020 Nov; 267(11):3235-3242. PubMed ID: 32542526
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Myotonic dystrophy health index: Correlations with clinical tests and patient function.
    Heatwole C; Bode R; Johnson NE; Dekdebrun J; Dilek N; Eichinger K; Hilbert JE; Logigian E; Luebbe E; Martens W; Mcdermott MP; Pandya S; Puwanant A; Rothrock N; Thornton C; Vickrey BG; Victorson D; Moxley RT
    Muscle Nerve; 2016 Feb; 53(2):183-90. PubMed ID: 26044513
    [TBL] [Abstract][Full Text] [Related]  

  • 24. French translation and cross-cultural adaptation of The Myotonic Dystrophy Health Index.
    Gagnon C; Tremblay M; CôTé I; Heatwole C
    Muscle Nerve; 2018 Apr; 57(4):686-689. PubMed ID: 29053894
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [DM1 with severe fatigue: a cognitive behavioural therapy trial].
    Chapon F
    Med Sci (Paris); 2018 Nov; 34 Hors série n°2():43. PubMed ID: 30418147
    [No Abstract]   [Full Text] [Related]  

  • 26. Activities of daily living in myotonic dystrophy type 1.
    Landfeldt E; Nikolenko N; Jimenez-Moreno C; Cumming S; Monckton DG; Faber CG; Merkies ISJ; Gorman G; Turner C; Lochmüller H
    Acta Neurol Scand; 2020 May; 141(5):380-387. PubMed ID: 31889295
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reconstructing the Rasch-Built Myotonic Dystrophy Type 1 Activity and Participation Scale.
    Hermans MC; Hoeijmakers JG; Faber CG; Merkies IS
    PLoS One; 2015; 10(10):e0139944. PubMed ID: 26484877
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multidimensional aspects of pain in myotonic dystrophies.
    Peric M; Peric S; Rapajic N; Dobricic V; Savic-Pavicevic D; Nesic I; Radojicic S; Novakovic I; Lavrnic D; Rakocevic-Stojanovic V
    Acta Myol; 2015 Dec; 34(2-3):126-32. PubMed ID: 27199540
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of the functional capacity outcome measures for myotonic dystrophy.
    Jimenez-Moreno AC; Nikolenko N; Kierkegaard M; Blain AP; Newman J; Massey C; Moat D; Sodhi J; Atalaia A; Gorman GS; Turner C; Lochmüller H
    Ann Clin Transl Neurol; 2019 Aug; 6(8):1487-1497. PubMed ID: 31402614
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cognitive, neuropsychological and emotional-behavioural functioning in a sample of children with myotonic dystrophy type 1.
    Ricci FS; Vacchetti M; Brusa C; D'Alessandro R; La Rosa P; Martone G; Davico C; Vitiello B; Mongini TE
    Eur J Paediatr Neurol; 2022 Jul; 39():59-64. PubMed ID: 35679764
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chronic exercise mitigates disease mechanisms and improves muscle function in myotonic dystrophy type 1 mice.
    Manta A; Stouth DW; Xhuti D; Chi L; Rebalka IA; Kalmar JM; Hawke TJ; Ljubicic V
    J Physiol; 2019 Mar; 597(5):1361-1381. PubMed ID: 30628727
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Elevated serum Neurofilament Light chain (NfL) as a potential biomarker of neurological involvement in Myotonic Dystrophy type 1 (DM1).
    Nicoletti TF; Rossi S; Vita MG; Perna A; Guerrera G; Lino F; Iacovelli C; Di Natale D; Modoni A; Battistini L; Silvestri G
    J Neurol; 2022 Sep; 269(9):5085-5092. PubMed ID: 35575811
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cognitive behavioural therapy in chronic fatigue syndrome: a randomised controlled trial of an outpatient group programme.
    O'Dowd H; Gladwell P; Rogers CA; Hollinghurst S; Gregory A
    Health Technol Assess; 2006 Oct; 10(37):iii-iv, ix-x, 1-121. PubMed ID: 17014748
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Psychological characteristics of patients with myotonic dystrophy type 1.
    Bertrand JA; Jean S; Laberge L; Gagnon C; Mathieu J; Gagnon JF; Richer L
    Acta Neurol Scand; 2015 Jul; 132(1):49-58. PubMed ID: 25496310
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prospective measurement of quality of life in myotonic dystrophy type 1.
    Peric S; Heatwole C; Durovic E; Kacar A; Nikolic A; Basta I; Marjanovic A; Stevic Z; Lavrnic D; Rakocevic Stojanovic V
    Acta Neurol Scand; 2017 Dec; 136(6):694-697. PubMed ID: 28660733
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Abnormal functional brain connectivity and personality traits in myotonic dystrophy type 1.
    Serra L; Silvestri G; Petrucci A; Basile B; Masciullo M; Makovac E; Torso M; Spanò B; Mastropasqua C; Harrison NA; Bianchi ML; Giacanelli M; Caltagirone C; Cercignani M; Bozzali M
    JAMA Neurol; 2014 May; 71(5):603-11. PubMed ID: 24664202
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Brief assessment of cognitive function in myotonic dystrophy: Multicenter longitudinal study using computer-assisted evaluation.
    Deutsch GK; Hagerman KA; Sampson J; Dent G; Dekdebrun J; Parker DM; Thornton CA; Heatwole CR; Subramony SH; Mankodi AK; Ashizawa T; Statland JM; Arnold WD; Moxley RT; Day JW;
    Muscle Nerve; 2022 May; 65(5):560-567. PubMed ID: 35179228
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Twenty-four-hour ambulatory ECG monitoring relevancy in myotonic dystrophy type 1 follow-up: Prognostic value and heart rate variability evolution.
    Gamet A; Degand B; Le Gal F; Bidegain N; Delaubier A; Gilbert-Dussardier B; Christiaens L; Garcia R
    Ann Noninvasive Electrocardiol; 2019 Jan; 24(1):e12587. PubMed ID: 30101452
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Health supervision and anticipatory guidance in adult myotonic dystrophy type 1.
    Gagnon C; Chouinard MC; Laberge L; Veillette S; Bégin P; Breton R; Jean S; Brisson D; Gaudet D; Mathieu J;
    Neuromuscul Disord; 2010 Dec; 20(12):847-51. PubMed ID: 20884209
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Consensus-Based Care Recommendations for Pulmonologists Treating Adults with Myotonic Dystrophy Type 1.
    Boentert M; Cao M; Mass D; De Mattia E; Falcier E; Goncalves M; Holland V; Katz SL; Orlikowski D; Sannicolò G; Wijkstra P; Hellerstein L; Sansone VA
    Respiration; 2020; 99(4):360-368. PubMed ID: 32299079
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.